Fatty acid transport proteins and insulin resistance

Current Opinion in Lipidology

Volumn 16, Issue 2, 2005, Pages 173-178

  Fisher, Rachel M ^a   Gertow, Karl ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acyl CoA synthase; Fatty acid transport protein; Fatty acids; Insulin resistance

Indexed keywords

CARRIER PROTEIN; FATTY ACID; FATTY ACID TRANSPORT PROTEIN 1; FATTY ACID TRANSPORT PROTEIN 4; FATTY ACID TRANSPORTER; LONG CHAIN FATTY ACID COENZYME A LIGASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID DIET; LIPID STORAGE; METABOLIC BALANCE; MUSCLE LEVEL; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 17144370240     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mol.0000162322.39548.b1     Document Type: Review

References (40)

1. Hirsch D, Stahl A, Lodish HF. A family of fatty acid transporters conserved from mycobacterium to man. Proc Natl Acad Sci U S A 1998; 95:8625-8629.
2. Schaffer JE, Lodish HF. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 1994; 79:427-436.
3. Stahl A. A current review of fatty acid transport proteins (SLC27). Pflugers Arch 2004; 447:722-727. A concise review of the FATP family, which considers structure-function aspects, regulation of expression and mechanism of action.
4. Pohl J, Ring A, Herrmann T, Stremmel W. Role of FATP in parenchymal cell fatty acid uptake. Biochim Biophys Acta 2004; 1686:1-6.
5. Linger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2004; 144:5159-5164.
6. Stahl A, Evans JG, Pattel S, et al. Insulin causes fatty acid transport protein translocation and enhanced fatty acid uptake in adipocytes. Dev Cell 2002; 2:477-488.
7. Black PN, DiRusso CC. Transmembrane movement of exogenous long-chain fatty acids: proteins, enzymes, and vectorial esterification. Microbiol Mol Biol Rev 2004; 67:454-472. A comprehensive review of the roles of FATP and ACS in transmembrane fatty acid transport coupled to activation of acyl-CoA, drawing on the data gathered from bacterial and yeast model systems.
8. Kalant D, Cianflone K. Regulation of fatty acid transport. Curr Opin Lipidol 2004; 15:309-314. An excellent short review of the current thinking relating to fatty acid transport covering FATPs as well as CD36 and the plasma membrane fatty acid binding protein.
9. Hall AM, Smith AJ, Bernlohr DA. Characterization of the acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem 2003; 278:43008-43013. This article provides a clear demonstration that purified FATP1 has intrinsic ACS activity with a broad specificity for both LCFAs and VLCFAs. Interestingly, FATP1 is a low velocity enzyme compared with ACS1 and is not inhibited by Triacsin C, a potent competitive inhibitor of ACS1, suggesting nonoverlapping roles for FATP1 and ACS1.
10. Gertow K, Bellanda M, Eriksson P, et al. Genetic and structural evaluation of fatty acid transport protein-4 in relation to markers of the insulin resistance syndrome. J Clin Endocrinol Metab 2004; 89:392-399. This study showed that the Gly209Ser polymorphism within FATP4 was associated with parameters of insulin resistance in 50-year-old healthy men. Furthermore, a three-dimensional protein model was generated for FATP4, which also classified FATP4 as an ACS using a complementary approach to the previous reference. This model identified regions of FATP4 with specific functions and placed the variable 209 residue on a surface that may be involved in protein-protein interactions.
11. Mashek DG, Bornfeldt KE, Coleman RA, et al. Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res 2004; 45:1958-1961.
12. Kampf JP, Kleinfeld AM. Fatty acid transport in adipocytes monitored by imaging intracellular free fatty acid levels. J Biol Chem 2004; 279:35775-35780. In this elegant study, the fluorescent probe ADIFAB was used to measure intracellular concentrations of unbound fatty acids in adipocytes. Fatty acid influx was saturable, highly regulated and required ATP. The kinetics of fatty acid transport across the adipocyte membrane could not be explained by simple diffusion and instead suggested protein-mediated transport. FATP-mediated transport fits well with these data.
13. Schmelter T, Trigatti BL, Gerber GE, Mangroo D. Biochemical demonstration of the involvement of fatty acyl-CoA synthetase in fatty acid translocation across the plasma membrane. J Biol Chem 2004; 279:24163-24170.
14. Marszalek JR, Kitidis C, Dararutana A, Lodish HF. Acyl-CoA synthetase 2 overexpression enhances fatty acid internalization and neurite outgrowth. J Biol Chem 2004; 279:23882-23891.
15. Caviglia JM, Li LO, Wang S, et al. Rat long chain acyl-CoA synthetase 5, but not 1, 2, 3, or 4, complements Escherichia coli fadD. J Biol Chem 2004; 279:11163-11169.
16. Kim JK, Gimeno RE, Higashimori T, et al. Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle. J Clin Invest 2004; 113:756-763. The generation of FATP1 knockout mice demonstrated a role for FATP1 in fat accumulation in muscle in the face of increased lipid supply. This represents an important link between FATP1 and insulin resistance since intramuscular fat accumulation is closely linked to defects in insulin signalling.
17. Hatch GM, Smith AJ, Xu F-Y, et al. FATP1 channels exogenous FA into 1,2,3-triacyl-sn-glycerol and down-regulates sphingomyelin and cholesterol metabolism in growing 293 cells. J Lipid Res 2002; 43:1380-1389.
18. Souza SC, Muliro KV, Liscum L, et al. Modulation of hormone-sensitive lipase and proiein kinase A-mediated lipolysis by perlipin A in an adenoviral reconstituted system. J Biol Chem 2002; 277:8267-8272.
19. Marotta M, Ferrer-Martinez A, Parnau J, et al. Fiber type- and fatty acid composition-dependent effects of high-fat diets on rat muscle triacylglyceride and fatty acid transport protein-1 content. Metabolism 2004; 53:1032-1036. This article provides further evidence for a link between FATP1-mediated fatty acid uptake into skeletal muscle and lipid accumulation in the face of increased lipid supply.
20. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002; 8:731-737.
21. Gertow K, Pietiläinen K, Yki-Järvinen H, et al. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance. Diabetologia 2004; 47:1118-1125. An elegant study design allowed discrimination between influences of genetic and nongenetic factors on gene expression in human adipose tissue. FATP4 expression was increased in acquired obesity (independent of genetic factors), indicating a strong influence of environmental and lifestyle factors on FATP4 expression. This suggests that FATP4 may be an appropriate pharmaceutical target for the treatment of obesity and associated insulin resistance.
22. Kannisto K, Sutinen J, Korsheninnikova E, et al. Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy. AIDS 2002; 17:1753-1762.
23. Sutinen J, Kannisto K, Korsheninnikova E, et al. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 2004; 286:E941-E949.
24. Herrmann T, van der Hoeven F, Gröne H-J, et al. Mice with targeted disruption of the fatty acid transport protein 4 (Fatp4, Slc27a4) gene show features of lethal restrictive dermopathy. J Cell Biol 2003; 161:1105-1115
25. Mouslon CL, Martin DR, Lugus JL, et al. Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development. Proc Natl Acad Sci USA 2003; 100:5274-5279.
26. Gimeno RE, Hirsch DJ, Punreddy S, et al. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 2003; 278:49512-49516. This article, the second report of an FATP4-ablated mouse, implicates FATP4 as having an important role in maternal-foetal transport of fatty acids. Despite low fatty acid uptake into isolated enterocytes from heterozygous mice, surprisingly there was no effect on dietary fat absorption. This study does not investigate the effect of FATP4 heterozygosity on insulin sensitivity, but it does reveal other vital functions for FATP4, which are not compensated for by other proteins involved in fatty acid transport/metabolism.
27. Heinzer AK, Watkins PA, Lu J-F, et al. A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy. Hum Mol Gen 2004; 12:1145-1154. This study characterizes an FATP2 knockout mouse. It shows FATP2 to have a functional role in peroxisomal LCFA activation and oxidation, but does not address whether this is of importance for parameters related to insulin sensitivity.
28. Jia Z, Pei Z, Li Y, et al. X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases. Mol Genet Metab 2004; 83:117-127.
29. Pei Z, Fraisl P, Berger J, et al. Mouse very long-chain acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells. J Biol Chem 2004; 6 October (Epub ahead of print). This is the first characterization of FATP3. It is shown to have ACS activity against both LCFAs and VLCFAs and to locate to mitochondria. Although the designation of FATP3 as a fatty acid transporter is questioned, this study underlines the important role(s) of FATPs in cellular fatty acid metabolism.
30. Mihalik SJ, Steinberg SJ, Pei Z, et al. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling. J Biol Chem 2002; 277:24771-24779.
31. Gimeno RE, Ortegon AM, Patel S, et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003; 278:16039-16044.
32. Chiu H-C, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001; 107:813-822.
33. Lee Y, Naseem RH, Duplomb L, et al. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci U S A 2004; 101:13624-13629. This interesting study shows that the effect of increased cardiomyocte ACS expression resulting in harmful lipid accumulation within the heart can be reversed by lowering the availability of substrate fatty acids and increasing fatty acid oxidation. By analogy, this study implies that the effects of increased FATP expression need to be considered in the context of fatty acid supply and utilization, and emphasizes an important role in tissue lipotoxicity.
34. Gargiulo CE, Stuhlsatz-Krouper SM, Schaffer JE. Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. J Lipid Res 1999; 40:881-892.
35. Richards MR, Listenberger LL, Kelly AA, et al. Oligomerization of the murine fatty acid transport protein 1. J Biol Chem 2003; 273:10477-10483.
36. Hisanaga Y, Ago H, Nakagawa N, et al. Structural basis of the substrate-specific two-step catalysis of long chain fatty acyl-CoA synthetase dimer. J Biol Chem 2004; 279:31717-31726. The crystallization of a long-chain ACS from T. thermophilus provides evidence that activation of fatty acids occurs in two steps: binding of ATP followed by a conformational change allowing access of the fatty acid-binding tunnel to ATP resulting in fatty acyl-CoA formation. Furthermore, this ACS was shown to function as a homodimer. These data support the concept that the FATPs function as dimers and provide further insight into structure-function aspects.
37. Jogl G, Tong L. Crystal structure of yeast acetyl-coenzyme A synthetase in complex with AMP. Biochemistry 2004; 43:1425-1431.
38. Pohl J, Ring A, Korkmaz Ü, et al. FAT/CD36 mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell 2004; 20 October (Epub ahead of print).
39. Pohl J, Ring A, Ehehalt R, et al. New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. Proc Nutr Soc 2004; 63:259-262.
40. Bonen A, Parolin ML, Steinberg GR, et al. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 2004; 18:1144-1146. This paper provides further support for the theory that the active trans-membrane transport of fatty acids is of importance in insulin resistance in man. Increased intramuscular triacylglycerol accumulation in type 2 diabetes was related to increased fatty acid uptake and expression of CD36. This complements the observations that higher levels of FATP1 expression are associated with greater intramuscular fat deposition and implicates this process in the pathogenesis of insulin resistance.